Teresa Brophy Bair's most recent trade in Kura Oncology Inc was a trade of 4,777 Common Stock done at an average price of $8.5 . Disclosure was reported to the exchange on Jan. 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.46 per share. | 27 Jan 2026 | 4,777 | 226,931 (0%) | 0% | 8.5 | 40,417 | Common Stock |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.46 per share. | 27 Jan 2026 | 4,096 | 234,043 (0%) | 0% | 8.5 | 34,655 | Common Stock |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.46 per share. | 27 Jan 2026 | 2,335 | 231,708 (0%) | 0% | 8.5 | 19,756 | Common Stock |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 100,000 | 100,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 50,000 | 238,139 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2025 | 48,900 | 196,943 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 11.18 per share. | 13 Nov 2025 | 8,804 | 188,139 (0%) | 0% | 11.2 | 98,401 | Common Stock |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2025 | 48,900 | 156,848 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.94 per share. | 27 Sep 2025 | 8,805 | 148,043 (0%) | 0% | 8.9 | 78,736 | Common Stock |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 5.96 per share. | 19 May 2025 | 1,559 | 107,948 (0%) | 0% | 6.0 | 9,292 | Common Stock |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.87 per share. | 28 Jan 2025 | 4,844 | 107,948 (0%) | 0% | 7.9 | 38,131 | Common Stock |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.87 per share. | 28 Jan 2025 | 2,437 | 112,792 (0%) | 0% | 7.9 | 19,184 | Common Stock |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 92,500 | 92,500 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 46,250 | 115,229 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 22.15 per share. | 20 May 2024 | 2,615 | 68,979 (0%) | 0% | 22.1 | 57,916 | Common Stock |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 17.80 per share. | 29 Jan 2024 | 2,053 | 68,979 (0%) | 0% | 17.8 | 36,544 | Common Stock |
| Kura Oncology Inc | Bair Brophy Teresa | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 92,500 | 92,500 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Bair Teresa Brophy | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 46,250 | 71,032 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 138,750 | 138,750 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 23,125 | 23,125 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Teresa Brophy Bair | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 15.22 per share. | 17 Nov 2022 | 2,100 | 0 (0%) | 0% | 15.2 | 31,965 | Common Stock |